We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+20.67%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$359M
AUM Growth
+$22.8M
Cap. Flow
-$158K
Cap. Flow %
-0.04%
Top 10 Hldgs %
58.31%
Holding
131
New
16
Increased
29
Reduced
30
Closed
17

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$2.71M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$1.99M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.98M
4
PLTR icon
Palantir
PLTR
+$1.69M
5
UAA icon
Under Armour
UAA
+$1.53M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$4.04M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.32M
3
GPN icon
Global Payments
GPN
+$2.26M
4
XYZ
Block Inc
XYZ
+$2.21M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$1.65M

Sector Composition

Rank Sector Weight
1 Healthcare 28.92%
2 Technology 25.58%
3 Communication Services 17.05%
4 Consumer Discretionary 16.61%
5 Miscellaneous 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPOT icon
1
Spotify
SPOT
$113B
$40.1M 11.18%
213,000
-3,000
-1% -$524K
SHOP icon
2
Shopify
SHOP
$197B
$31.4M 8.74%
415,000
– –
TSLA icon
3
Tesla
TSLA
$1.38T
$29.4M 8.19%
118,300
+5,300
+5% +$1.26M
SNOW icon
4
Snowflake
SNOW
$114B
$24.9M 6.93%
129,000
– –
AMZN icon
5
Amazon
AMZN
$2.87T
$21.3M 5.92%
141,000
– –
OXY.WS icon
6
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$18.9M 5.28%
496,207
-18,000
-4% -$705K
IONS icon
7
Ionis Pharmaceuticals
IONS
$10.1B
$11.5M 3.2%
217,493
-11,000
-5% -$527K
PRQR icon
8
ProQR Therapeutics
PRQR
$323M
$11.1M 3.1%
5,344,446
– –
ROKU icon
9
Roku
ROKU
$23.4B
$10.8M 3%
120,000
+10,000
+9% +$836K
MRK icon
10
Merck
MRK
$366B
$9.96M 2.78%
87,978
– –
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.24T
$9.67M 2.69%
70,000
-5,000
-7% -$672K
ARWR icon
12
Arrowhead Research
ARWR
$12B
$8.49M 2.37%
273,936
+14,900
+6% +$396K
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.52B
$8.02M 2.23%
166,506
+51,265
+44% +$1.99M
DDOG icon
14
Datadog
DDOG
$85.1B
$7.79M 2.17%
65,993
+3,500
+6% +$361K
PLTR icon
15
Palantir
PLTR
$448B
$7.13M 1.99%
425,000
+95,000
+29% +$1.69M
RCKT icon
16
Rocket Pharmaceuticals
RCKT
$424M
$6.87M 1.92%
233,050
+89,700
+63% +$1.98M
ITCI
17
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.62M 1.85%
93,983
+333
+0.4% +$19.2K
ZLAB icon
18
Zai Lab
ZLAB
$2.93B
$6.27M 1.75%
240,683
– –
VRTX icon
19
Vertex Pharmaceuticals
VRTX
$137B
$6.21M 1.73%
15,116
-6,279
-29% -$2.32M
NET icon
20
Cloudflare
NET
$107B
$5.95M 1.66%
75,000
– –
MSFT icon
21
Microsoft
MSFT
$3.81T
$5.93M 1.65%
16,000
– –
AXSM icon
22
Axsome Therapeutics
AXSM
$10.4B
$5.55M 1.55%
72,032
– –
MRNA icon
23
Moderna
MRNA
$55.1B
$4.93M 1.37%
43,861
– –
SE icon
24
Sea Limited
SE
$73.1B
$4.64M 1.29%
118,000
+20,000
+20% +$816K
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$31.7B
$4.23M 1.18%
21,693
+1,670
+8% +$284K
1
2 3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q4 2023 Portfolio in Review

As of Q4 2023, Privium Fund Management held 131 positions worth $359M, up 6.8% from $336M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Privium Fund Management's Q4 2023 filing shows 16 new, 29 increased, 30 reduced and 17 closed positions. Its largest new stake was Roivant Sciences: 277,795 shares worth $3.15M. The largest sale was argenx, an estimated $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.

  • Privium Fund Management's largest Q4 2023 buy was Roivant Sciences: 277,795 shares worth $3.15M.
  • Privium Fund Management added most to Ultragenyx Pharmaceutical in Q4 2023, an estimated $1.99M increase.
  • Privium Fund Management's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $2.32M.
  • Privium Fund Management fully exited argenx in Q4 2023, selling an estimated $4.04M.
  • Privium Fund Management's ten largest holdings make up 58% of its $359M portfolio in Q4 2023.
  • Privium Fund Management opened 16 new positions and closed 17 in Q4 2023.
  • Privium Fund Management's portfolio value rose 6.8% quarter-over-quarter to $359M.

Based on Privium Fund Management's 13F filing for Q4 2023, filed 13 Feb 2024.